222 related articles for article (PubMed ID: 30885958)
41. Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: A review of effects on the breast.
Pickar JH; Komm BS
Post Reprod Health; 2015 Sep; 21(3):112-21. PubMed ID: 26289836
[TBL] [Abstract][Full Text] [Related]
42. Scutellaria barbata D. Don inhibits colorectal cancer growth via suppression of Wnt/β-catenin signaling pathway.
Wei LH; Lin JM; Chu JF; Chen HW; Li QY; Peng J
Chin J Integr Med; 2017 Nov; 23(11):858-863. PubMed ID: 29080197
[TBL] [Abstract][Full Text] [Related]
43. Pharmacologic inhibition of IL11/STAT3 signaling increases MHC-I expression and T cell infiltration.
Xiong W; Chen Y; Zhang C; Li J; Huang H; Zhu Y; Deng G; Cheng J; Lin Y; Shi Z; Mou T
J Transl Med; 2023 Jun; 21(1):416. PubMed ID: 37365574
[TBL] [Abstract][Full Text] [Related]
44. IL-6/gp130/STAT3 signaling contributed to the activation of the PERK arm of the unfolded protein response in response to chronic β-adrenergic stimulation.
Men L; Guo J; Cao Y; Huang B; Wang Q; Huo S; Wang M; Peng D; Peng L; Shi W; Li S; Lin L; Lv J
Free Radic Biol Med; 2023 Aug; 205():163-174. PubMed ID: 37307935
[TBL] [Abstract][Full Text] [Related]
45. Activation of interleukin-6-induced glycoprotein 130/signal transducer and activator of transcription 3 pathway in mesenchymal stem cells enhances hepatic differentiation, proliferation, and liver regeneration.
Lam SP; Luk JM; Man K; Ng KT; Cheung CK; Rose-John S; Lo CM
Liver Transpl; 2010 Oct; 16(10):1195-206. PubMed ID: 20879018
[TBL] [Abstract][Full Text] [Related]
46. Discovery of a novel orally active small-molecule gp130 inhibitor for the treatment of ovarian cancer.
Xu S; Grande F; Garofalo A; Neamati N
Mol Cancer Ther; 2013 Jun; 12(6):937-49. PubMed ID: 23536726
[TBL] [Abstract][Full Text] [Related]
47. Induction and down-regulation of Sox17 and its possible roles during the course of gastrointestinal tumorigenesis.
Du YC; Oshima H; Oguma K; Kitamura T; Itadani H; Fujimura T; Piao YS; Yoshimoto T; Minamoto T; Kotani H; Taketo MM; Oshima M
Gastroenterology; 2009 Oct; 137(4):1346-57. PubMed ID: 19549530
[TBL] [Abstract][Full Text] [Related]
48. The Innate Immune Receptor NLRX1 Functions as a Tumor Suppressor by Reducing Colon Tumorigenesis and Key Tumor-Promoting Signals.
Koblansky AA; Truax AD; Liu R; Montgomery SA; Ding S; Wilson JE; Brickey WJ; Mühlbauer M; McFadden RM; Hu P; Li Z; Jobin C; Lund PK; Ting JP
Cell Rep; 2016 Mar; 14(11):2562-75. PubMed ID: 26971998
[TBL] [Abstract][Full Text] [Related]
49. STAT3 activation regulates growth, inflammation, and vascularization in a mouse model of gastric tumorigenesis.
Judd LM; Bredin K; Kalantzis A; Jenkins BJ; Ernst M; Giraud AS
Gastroenterology; 2006 Oct; 131(4):1073-85. PubMed ID: 17030178
[TBL] [Abstract][Full Text] [Related]
50. A myeloid-stromal niche and gp130 rescue in NOD2-driven Crohn's disease.
Nayar S; Morrison JK; Giri M; Gettler K; Chuang LS; Walker LA; Ko HM; Kenigsberg E; Kugathasan S; Merad M; Chu J; Cho JH
Nature; 2021 May; 593(7858):275-281. PubMed ID: 33789339
[TBL] [Abstract][Full Text] [Related]
51. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
[TBL] [Abstract][Full Text] [Related]
52. gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis.
Bollrath J; Phesse TJ; von Burstin VA; Putoczki T; Bennecke M; Bateman T; Nebelsiek T; Lundgren-May T; Canli O; Schwitalla S; Matthews V; Schmid RM; Kirchner T; Arkan MC; Ernst M; Greten FR
Cancer Cell; 2009 Feb; 15(2):91-102. PubMed ID: 19185844
[TBL] [Abstract][Full Text] [Related]
53. Continuous glycoprotein-130-mediated signal transducer and activator of transcription-3 activation promotes inflammation, left ventricular rupture, and adverse outcome in subacute myocardial infarction.
Hilfiker-Kleiner D; Shukla P; Klein G; Schaefer A; Stapel B; Hoch M; Müller W; Scherr M; Theilmeier G; Ernst M; Hilfiker A; Drexler H
Circulation; 2010 Jul; 122(2):145-55. PubMed ID: 20585009
[TBL] [Abstract][Full Text] [Related]
54. Astrocyte differentiation of fetal neuroepithelial cells by interleukin-11 via activation of a common cytokine signal transducer, gp130, and a transcription factor, STAT3.
Yanagisawa M; Nakashima K; Arakawa H; Ikenaka K; Yoshida K; Kishimoto T; Hisatsune T; Taga T
J Neurochem; 2000 Apr; 74(4):1498-504. PubMed ID: 10737606
[TBL] [Abstract][Full Text] [Related]
55. Interleukin-11-driven gastric tumourigenesis is independent of trans-signalling.
Balic JJ; Garbers C; Rose-John S; Yu L; Jenkins BJ
Cytokine; 2017 Apr; 92():118-123. PubMed ID: 28160627
[TBL] [Abstract][Full Text] [Related]
56. A hypermorphic epithelial β-catenin mutation facilitates intestinal tumorigenesis in mice in response to compounding WNT-pathway mutations.
Buchert M; Rohde F; Eissmann M; Tebbutt N; Williams B; Tan CW; Owen A; Hirokawa Y; Gnann A; Orend G; Orner G; Dashwood RH; Heath JK; Ernst M; Janssen KP
Dis Model Mech; 2015 Nov; 8(11):1361-73. PubMed ID: 26398937
[TBL] [Abstract][Full Text] [Related]
57. Lack of gp130 expression in hepatocytes attenuates tumor progression in the DEN model.
Hatting M; Spannbauer M; Peng J; Al Masaoudi M; Sellge G; Nevzorova YA; Gassler N; Liedtke C; Cubero FJ; Trautwein C
Cell Death Dis; 2015 Mar; 6(3):e1667. PubMed ID: 25741592
[TBL] [Abstract][Full Text] [Related]
58. The pro-regenerative effects of hyperIL6 in drug-induced liver injury are unexpectedly due to competitive inhibition of IL11 signaling.
Dong J; Viswanathan S; Adami E; Schafer S; Kuthubudeen FF; Widjaja AA; Cook SA
Elife; 2021 Aug; 10():. PubMed ID: 34435951
[TBL] [Abstract][Full Text] [Related]
59. Tetraspanin CD9 stabilizes gp130 by preventing its ubiquitin-dependent lysosomal degradation to promote STAT3 activation in glioma stem cells.
Shi Y; Zhou W; Cheng L; Chen C; Huang Z; Fang X; Wu Q; He Z; Xu S; Lathia JD; Ping Y; Rich JN; Bian XW; Bao S
Cell Death Differ; 2017 Jan; 24(1):167-180. PubMed ID: 27740621
[TBL] [Abstract][Full Text] [Related]
60. Hyperactive gp130/STAT3-driven gastric tumourigenesis promotes submucosal tertiary lymphoid structure development.
Hill DG; Yu L; Gao H; Balic JJ; West A; Oshima H; McLeod L; Oshima M; Gallimore A; D'Costa K; Bhathal PS; Sievert W; Ferrero RL; Jenkins BJ; Jones GW
Int J Cancer; 2018 Jul; 143(1):167-178. PubMed ID: 29417587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
